School of Population Health, University of Queensland, Herston, QLD, Australia; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, QLD, Australia.
J Child Psychol Psychiatry. 2013 Dec;54(12):1263-74. doi: 10.1111/jcpp.12144. Epub 2013 Oct 4.
The most recent Global Burden of Disease Study (GBD 2010) is the first to include attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) for burden quantification. We present the epidemiological profiles of ADHD and CD across three time periods for 21 world regions.
A systematic review of global epidemiology was conducted for each disorder (based on a literature search of the Medline, PsycInfo and EMBASE databases). A Bayesian metaregression tool was used to derive prevalence estimates by age and sex in three time periods (1990, 2005 and 2010) for 21 world regions including those with little or no data. Prior expert knowledge and covariates were applied to each model to adjust suboptimal data. Final prevalence output for ADHD were adjusted to reflect an equivalent value if studies had measured point prevalence using multiple informants while final prevalence output for CD were adjusted to reflect a value equivalent to CD only.
Prevalence was pooled for males and females aged 5-19 years with no difference found in global prevalence between the three time periods. Male prevalence of ADHD in 2010 was 2.2% (2.0-2.3) while female prevalence was 0.7% (0.6-0.7). Male prevalence of CD in 2010 was 3.6% (3.3-4.0) while female prevalence was 1.5% (1.4-1.7). ADHD and CD were estimated to be present worldwide with ADHD prevalence showing some regional variation while CD prevalence remained relatively consistent worldwide.
We present the first prevalence estimates of both ADHD and CD globally and for all world regions. Data were sparse with large parts of the world having no estimates of either disorder. Epidemiological studies are urgently needed in certain parts of the world. Our findings directly informed burden quantification for GBD 2010. As mental disorders gained increased recognition after the first GBD study in 1990, the inclusion of ADHD and CD in GBD 2010 ensures their importance will be recognized alongside other childhood disorders.
最近的全球疾病负担研究(GBD 2010)是第一个将注意力缺陷/多动障碍(ADHD)和品行障碍(CD)纳入负担量化的研究。我们呈现了 21 个世界区域在三个时期的 ADHD 和 CD 的流行病学特征。
对每种疾病(基于 Medline、PsycInfo 和 EMBASE 数据库的文献检索)进行了全球流行病学的系统回顾。使用贝叶斯荟萃回归工具,根据年龄和性别,在三个时期(1990 年、2005 年和 2010 年),对包括数据很少或没有数据的 21 个世界区域,得出患病率估计值。对每个模型应用先前的专家知识和协变量,以调整数据不佳的情况。如果研究使用多个信息源测量时点患病率,则对 ADHD 的最终患病率进行调整,以反映等效值;如果对 CD 的最终患病率进行调整,则反映与 CD 等效的值。
对 5-19 岁的男性和女性进行了患病率汇总,发现三个时期之间全球患病率没有差异。2010 年男性 ADHD 的患病率为 2.2%(2.0-2.3),而女性患病率为 0.7%(0.6-0.7)。2010 年男性 CD 的患病率为 3.6%(3.3-4.0),而女性患病率为 1.5%(1.4-1.7)。ADHD 和 CD 被估计在全球范围内存在,ADHD 的患病率存在一些区域差异,而 CD 的患病率在全球范围内相对稳定。
我们呈现了全球和所有世界区域 ADHD 和 CD 的首次患病率估计值。数据稀疏,世界上很大一部分地区都没有这两种疾病的估计值。世界上某些地区急需开展流行病学研究。我们的研究结果直接为 GBD 2010 的负担量化提供了信息。随着精神障碍在 1990 年第一次 GBD 研究后得到了更多的认可,ADHD 和 CD 在 GBD 2010 中的纳入确保了它们的重要性将与其他儿童期障碍一起得到认可。